Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
Internal Medicine Journal · 2024-09 · 54 (9) · 1450-1457
DOI: 10.1111/imj.16413 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, online erschienen am 26.07.2024. Verfasst von Brendan J Nolan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Transgender Persons, Testosterone, Estradiol. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, RACP Foundation.
Abstract (Originalsprache)
Gender‐affirming hormone therapy (GAHT) is used by many transgender and gender‐diverse adults to align physical characteristics with their gender identity, reduce gender incongruence and improve psychological functioning. This narrative review provides an overview of the initiation and monitoring of GAHT in an Australian context. Trans individuals treated with testosterone typically receive standard testosterone doses and formulations recommended for cisgender men, whereas those receiving estradiol GAHT are typically treated with estradiol in combination with an anti‐androgen in those without orchidectomy. Proactive monitoring and mitigation of cardiovascular risk factors is pertinent in all transgender and gender‐diverse adults and bone health is an important consideration in those using estradiol GAHT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
- Trans Health Research Group, Department of Medicine (Austin Health), University of Melbourne, Melbourne, Victoria, Australia.
- Equinox Gender Diverse Clinic, Thorne Harbour Health, Melbourne, Victoria, Australia.
- Department of Endocrinology, Austin Health, Melbourne, Victoria, Australia.
ORCID-Profile: Brendan J Nolan, Ada S Cheung
Förderung
- National Health and Medical Research Council
- RACP Foundation
Zitieren
APA
Nolan, B. J., & Cheung, A. S. (2024). Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia. Internal Medicine Journal, 54(9), 1450-1457. https://doi.org/10.1111/imj.16413
Vancouver
Nolan BJ, Cheung AS. Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia. Internal Medicine Journal. 2024;54(9):1450-1457. doi:10.1111/imj.16413
BibTeX
@article{Nolan2024,
author = {Nolan, Brendan J and Cheung, Ada S},
title = {Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia},
journal = {Internal Medicine Journal},
year = {2024},
volume = {54},
number = {9},
pages = {1450--1457},
doi = {10.1111/imj.16413}
}
EUVIMED